GEN Exclusives

More »

GEN News Highlights

More »
Mar 7, 2007

Cobra Joins Spore-Based Vaccine Consortium

  • Cobra Biomanufacturing became part of a consortium formed to develop a new vaccine delivery system based on live bacterial spores. The initial disease targets will be malaria and tuberculosis, but the spore-based approach represents a platform technology to deliver vaccines against a wide range of diseases.

    Spores of the harmless gut bacterium Bacillus subtilis are already taken orally as a probiotic to aid digestive health. The research program will involve genetically engineered spores to express vaccine determinants on their coat. Such spores are able to survive ingestion and can therefore deliver the vaccine to the immune system of the gut and induce immunity.

    Spores are stable and do not require cold storage, and the oral delivery will avoid the problems associated with needles, making this technology particularly valuable in developing countries.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »